Re: 'Heightened incidence of adverse events associated with a live attenuated varicella vaccine strain that lacks critical genetic polymorphisms in ORF62' by Kim et al

Young Woo Han; Seung Hye Hong; Seung Gu Kang; Seong-Beom Park; Hye Young Kim

doi:10.1016/j.cmi.2024.10.024

Re: 'Heightened incidence of adverse events associated with a live attenuated varicella vaccine strain that lacks critical genetic polymorphisms in ORF62' by Kim et al

Clin Microbiol Infect. 2024 Nov 2:S1198-743X(24)00506-8. doi: 10.1016/j.cmi.2024.10.024. Online ahead of print.

Authors

Young Woo Han¹, Seung Hye Hong¹, Seung Gu Kang², Seong-Beom Park², Hye Young Kim³

Affiliations

¹ Bio R&D Department, SK bioscience Co., Ltd., Seongnam, Republic of Korea.
² Medical Affairs, SK bioscience Co., Ltd., Seongnam, Republic of Korea.
³ Medical Affairs, SK bioscience Co., Ltd., Seongnam, Republic of Korea. Electronic address: [email protected].

PMID: 39491785
DOI: 10.1016/j.cmi.2024.10.024

No abstract available

Keywords: Adverse event; AlphaFold2; Live attenuated vaccine; Open reading frame; Protein structure prediction; Single-nucleotide polymorphism; Vaccine safety; Varicella vaccine; Varicella-zoster virus.

Publication types

Letter